Home › Funds › Two Sigma Investments › RLAY
Two Sigma Investments position in RLAY
RELAY THERAPEUTICS INC · Health Care
Latest position (Q2 2026)700.92K sh
Reported value held$13.11M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 191.89K | $6.05M | New |
| Q2 2022 | 23.91K | $400.00K | New |
| Q3 2023 | 400.67K | $3.37M | New |
| Q4 2023 | 404.92K | $4.46M | Add |
| Q1 2024 | 587.69K | $4.88M | Add |
| Q2 2024 | 730.02K | $4.76M | Add |
| Q3 2024 | 1.02M | $7.19M | Add |
| Q4 2024 | 816.09K | $3.36M | Reduce |
| Q1 2025 | 843.86K | $2.21M | Add |
| Q2 2025 | 1.02M | $3.54M | Add |
| Q3 2025 | 1.10M | $5.72M | Add |
| Q4 2025 | 1.56M | $13.20M | Add |
| Q1 2026 | 1.37M | $13.62M | Reduce |
| Q2 2026 | 700.92K | $13.11M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RLAY
- Fidelity Management & Research (FMR) 20.11M sh · $376.26M · Q2 2026
- Casdin Capital 16.04M sh · $300.02M · Q2 2026
- BlackRock Inc 15.29M sh · $286.04M · Q2 2026
- Geode Capital Management 4.73M sh · $88.45M · Q2 2026
- Vanguard Group 9.69M sh · $81.99M · Q4 2025
- Morgan Stanley 3.85M sh · $72.05M · Q2 2026
- Goldman Sachs Group 3.41M sh · $63.78M · Q2 2026
- Bank of America Corp 2.70M sh · $50.43M · Q2 2026
- Arrowstreet Capital 2.24M sh · $41.89M · Q2 2026
- Northern Trust Corp 1.95M sh · $36.55M · Q2 2026
- Franklin Resources 1.86M sh · $34.74M · Q2 2026
- Charles Schwab Investment Management 1.50M sh · $28.08M · Q2 2026